Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(Rev Mal Respir[TA]) articles in PubMed
4,793 results
  • [Lung adenocarcinoma with concomitant EGFR mutation and ALK rearrangement]. [Journal Article]
  • Rev Mal Respir 2016 Sep 16RM
  • Caliez J, Monnet I, … Chouaid C
  • CONCLUSIONS: The literature shows 45 other cases of these two abnormalities, observed either from the start or during follow-up. EGFR's TKI were almost always given before ALK's TKI.Therapeutic strategy needs to be clarified in cases of double alteration. With regard to the second patient, appearance of ALK rearrangement may constitute a resistance mechanism to EGFR's TKI.
  • [Progressive paralysis of the diaphragm following intra-abdominal chemotherapy]. [Journal Article]
  • Rev Mal Respir 2016 Sep 14RM
  • Guinard S, Olland A, … Massard G
  • CONCLUSIONS: We conclude in favor of a muscular degeneration of the diaphragm consecutive to the combined effect of cytoreductive surgery and intraperitoneal chemotherapy. Owing to the unusual nature of this complication, we did not consider it as a hypothesis at an early point in this patient's management. We think physicians should be aware of such a complication in order to consider it in a timely way. We recommend performing a biopsy of the diaphragm for pathology examination to assess muscular degeneration.
  • [Pulmonary infection with Mycobacterium malmoense. Difficulties in diagnosis and treatment]. [Journal Article]
  • Rev Mal Respir 2016 Sep 14RM
  • Huet D, Godbert B, … Andréjak C
  • CONCLUSIONS: This clinical case highlights the difficulties of diagnosing pulmonary atypical mycobacterial infection according to the American Thoracic Society criteria, particularly Mycobacterium malmoense, a non-tuberculous mycobacterium (NTM) quite uncommon in France. Currently, there are new diagnostic techniques such as GenoType Mycobacteria Direct(®). The second issue is the poorly standardized treatment of this NTM and many others, that are based on the recommendations of the British Thoracic Society. A national register has been set up by the MycoMed network, based essentially on the work of microbiologists but this register is unfortunately not exhaustive.A more systematic reporting strategy could allow cohort studies and therefore provide us with data on the most efficient drugs in the treatment of the rarest NTM infections.
  • [A not so poorly-defined opacity]. [Journal Article]
  • Rev Mal Respir 2016 Sep 13RM
  • Bravos E, Bayle-Bleuez S, … Bertoletti L
  • A 60-year-old patient was under follow-up for pulmonary hypertension consistent with pulmonary veno-occlusive disease. During his follow-up, a parenchymal opacity was discovered. We describe the mana...
  • [A well-inked pneumonia… can you decrypt it?] [Journal Article]
  • Rev Mal Respir 2016 Sep 9RM
  • Tetart M, Trosini-Désert V, … Chenivesse C
  • CONCLUSIONS: Although it is extremely rare, pulmonary cryptococcosis should be considered in immunocompetent patients presenting with necrotic pneumonia. Effectiveness of lymph node sampling can be improved by collaboration between clinicians and microbiologists.
  • [Lung neuroendocrine large-cell carcinoma in young women - An unusual presentation]. [Journal Article]
  • Rev Mal Respir 2016 Sep 8RM
  • Proux A, Greillier L, … Tomasini P
  • CONCLUSIONS: The clinical characteristics of these cases raise several questions about the pathophysiology of LNELCC and may suggest potential new treatment options. The unusual clinical presentation and good prognosis may be explained either by the second-line treatment choice or by potential molecular or hormonal biomarkers. There is a need to investigate these potential biomarkers further since they could be new therapeutic targets.
  • [Malignant rhabdoid tumor of the lung]. [Journal Article]
  • Rev Mal Respir 2016 Aug 29RM
  • Zysman M, Clement-Duchene C, … Martinet Y
  • CONCLUSIONS: The lack of expression of integrase interactor 1 should suggest the diagnosis of rhabdoid tumour, especially when there is quick progression. The prognosis of these tumours remains poor and therapeutic options are limited.
New Search Next